| Literature DB >> 32049042 |
Sarah-Maria Fendt1, Sophia Y Lunt2.
Abstract
The role of ROS in cancer is complex, with studies demonstrating both pro- and anti-tumor effects. In a pancreatic ductal adenocarcinoma model, ROS limitation through TIGAR has been shown to initially support cancer development but to later become a metabolic liability in metastasizing cells that is counteracted by decreased TIGAR expression.Entities:
Year: 2020 PMID: 32049042 DOI: 10.1016/j.ccell.2020.01.009
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743